Get the Stockscreener App
7.51
7.40%
-0.60
After Hours:
7.65
0.14
+1.86%
Rxsight Inc stock is traded at $7.51, with a volume of 1.24M.
It is down -7.40% in the last 24 hours and down -25.05% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$8.11
Open:
$8.16
24h Volume:
1.24M
Relative Volume:
1.11
Market Cap:
$307.28M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-9.1585
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-14.66%
1M Performance:
-25.05%
6M Performance:
-47.08%
1Y Performance:
-84.95%
1-Day Range:
$7.50
$8.16
1-Week Range:
$7.50
$8.96
52-Week Range:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.51 | 331.83M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
RxSight Inc. stock trend forecast2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Lacklustre Performance Is Driving RxSight, Inc.'s (NASDAQ:RXST) 25% Price Drop - simplywall.st
RxSight Inc. stock trend outlook and recovery pathStock Surge & Weekly High Return Stock Opportunities - newser.com
When is the best time to exit RxSight Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is RxSight Inc. stock bottoming out2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Candlestick signals on RxSight Inc. stock todayWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
RxSight's (RXST) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Full technical analysis of RxSight Inc. stock2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
What data driven models say about RxSight Inc.’s futureGap Down & Fast Moving Stock Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Can RxSight Inc. stock outperform in 2025 bull marketJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
How moving averages guide RxSight Inc. tradingPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in RxSight Inc.Stop Loss & Capital Efficient Trade Techniques - newser.com
Trend analysis for RxSight Inc. this week2025 Growth vs Value & Long-Term Growth Plans - newser.com
Is RxSight Inc. stock entering bullish territory2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is RxSight Inc a good long term investmentSwing Trading Ideas & Investment Recommendations You Can Trust - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
What drives RxSight Inc stock priceTop Performing Stocks & Outstanding Investment Returns - earlytimes.in
Head to Head Contrast: Monogram Orthopaedics (NASDAQ:MGRM) versus RxSight (NASDAQ:RXST) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
RxSight Inc Stock Analysis and ForecastTrend Following Strategies & Minimal Investment Portfolio - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - PR Newswire
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of “Reduce” from Brokerages - Defense World
Shareholders of RxSight, Inc. Should Contact Levi & - GlobeNewswire
RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Shareholders of RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to - Bluefield Daily Telegraph
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Business Wire
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rxsight Inc Stock (RXST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Weinberg Eric | See remarks |
Jun 02 '25 |
Option Exercise |
3.93 |
188,002 |
738,848 |
195,351 |
| Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
| Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):